Cancer Control-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1067378, encodeId=a0f6106e37895, content=审稿速度:7.0 | 投稿命中率:50.0 经验分享：3月底投稿，5月中一审，修改3次，润色1次，这个月已经online了。总体看来没有你们说的那么慢。但在等的时候，的确时间过得很慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3424242342, createdTime=Fri Nov 05 19:59:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917758, encodeId=a2fd91e75862, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：见过审稿慢的，但是真的没有见过这么慢的！Awaiting Decision快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=533, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Jan 18 16:07:29 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806224, encodeId=71ac80622419, content=没有战友投稿过吗？一审1.5月，修回还会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Wed Aug 05 07:17:38 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198039, encodeId=a2b7119803956, content=审稿速度:6.0 经验分享：21年10月8日投稿，12月初给了大修，12月底修回，22年2月24接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Mon Feb 28 15:23:17 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970605, encodeId=10c59e0605a0, content=偏重的研究方向：外科 ; 肿瘤 经验分享：前几天刚被接收，想问一下见刊需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8165418207, createdName=ms9000000466598327, createdTime=Thu Jun 03 15:41:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海)]

2021-11-05 ms3424242342

审稿速度:7.0 | 投稿命中率:50.0
经验分享：3月底投稿，5月中一审，修改3次，润色1次，这个月已经online了。总体看来没有你们说的那么慢。但在等的时候，的确时间过得很慢。

121 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067378, encodeId=a0f6106e37895, content=审稿速度:7.0 | 投稿命中率:50.0 经验分享：3月底投稿，5月中一审，修改3次，润色1次，这个月已经online了。总体看来没有你们说的那么慢。但在等的时候，的确时间过得很慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3424242342, createdTime=Fri Nov 05 19:59:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917758, encodeId=a2fd91e75862, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：见过审稿慢的，但是真的没有见过这么慢的！Awaiting Decision快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=533, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Jan 18 16:07:29 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806224, encodeId=71ac80622419, content=没有战友投稿过吗？一审1.5月，修回还会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Wed Aug 05 07:17:38 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198039, encodeId=a2b7119803956, content=审稿速度:6.0 经验分享：21年10月8日投稿，12月初给了大修，12月底修回，22年2月24接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Mon Feb 28 15:23:17 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970605, encodeId=10c59e0605a0, content=偏重的研究方向：外科 ; 肿瘤 经验分享：前几天刚被接收，想问一下见刊需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8165418207, createdName=ms9000000466598327, createdTime=Thu Jun 03 15:41:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海)]

2021-01-18 jfazj

审稿速度:12.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：见过审稿慢的，但是真的没有见过这么慢的！Awaiting Decision快1个月了

533 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067378, encodeId=a0f6106e37895, content=审稿速度:7.0 | 投稿命中率:50.0 经验分享：3月底投稿，5月中一审，修改3次，润色1次，这个月已经online了。总体看来没有你们说的那么慢。但在等的时候，的确时间过得很慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3424242342, createdTime=Fri Nov 05 19:59:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917758, encodeId=a2fd91e75862, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：见过审稿慢的，但是真的没有见过这么慢的！Awaiting Decision快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=533, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Jan 18 16:07:29 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806224, encodeId=71ac80622419, content=没有战友投稿过吗？一审1.5月，修回还会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Wed Aug 05 07:17:38 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198039, encodeId=a2b7119803956, content=审稿速度:6.0 经验分享：21年10月8日投稿，12月初给了大修，12月底修回，22年2月24接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Mon Feb 28 15:23:17 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970605, encodeId=10c59e0605a0, content=偏重的研究方向：外科 ; 肿瘤 经验分享：前几天刚被接收，想问一下见刊需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8165418207, createdName=ms9000000466598327, createdTime=Thu Jun 03 15:41:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海)]

2020-08-05 赤脚草医

没有战友投稿过吗？一审1.5月，修回还会被拒稿吗

139 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067378, encodeId=a0f6106e37895, content=审稿速度:7.0 | 投稿命中率:50.0 经验分享：3月底投稿，5月中一审，修改3次，润色1次，这个月已经online了。总体看来没有你们说的那么慢。但在等的时候，的确时间过得很慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3424242342, createdTime=Fri Nov 05 19:59:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917758, encodeId=a2fd91e75862, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：见过审稿慢的，但是真的没有见过这么慢的！Awaiting Decision快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=533, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Jan 18 16:07:29 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806224, encodeId=71ac80622419, content=没有战友投稿过吗？一审1.5月，修回还会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Wed Aug 05 07:17:38 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198039, encodeId=a2b7119803956, content=审稿速度:6.0 经验分享：21年10月8日投稿，12月初给了大修，12月底修回，22年2月24接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Mon Feb 28 15:23:17 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970605, encodeId=10c59e0605a0, content=偏重的研究方向：外科 ; 肿瘤 经验分享：前几天刚被接收，想问一下见刊需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8165418207, createdName=ms9000000466598327, createdTime=Thu Jun 03 15:41:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海)]

2022-02-28 Black doctor

审稿速度:6.0
经验分享：21年10月8日投稿，12月初给了大修，12月底修回，22年2月24接收

55 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067378, encodeId=a0f6106e37895, content=审稿速度:7.0 | 投稿命中率:50.0 经验分享：3月底投稿，5月中一审，修改3次，润色1次，这个月已经online了。总体看来没有你们说的那么慢。但在等的时候，的确时间过得很慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3424242342, createdTime=Fri Nov 05 19:59:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917758, encodeId=a2fd91e75862, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：见过审稿慢的，但是真的没有见过这么慢的！Awaiting Decision快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=533, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Jan 18 16:07:29 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806224, encodeId=71ac80622419, content=没有战友投稿过吗？一审1.5月，修回还会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Wed Aug 05 07:17:38 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198039, encodeId=a2b7119803956, content=审稿速度:6.0 经验分享：21年10月8日投稿，12月初给了大修，12月底修回，22年2月24接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Mon Feb 28 15:23:17 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970605, encodeId=10c59e0605a0, content=偏重的研究方向：外科 ; 肿瘤 经验分享：前几天刚被接收，想问一下见刊需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8165418207, createdName=ms9000000466598327, createdTime=Thu Jun 03 15:41:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海)]

2021-06-03 ms9000000466598327

偏重的研究方向：外科 ; 肿瘤
经验分享：前几天刚被接收，想问一下见刊需要多久啊？

94 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067378, encodeId=a0f6106e37895, content=审稿速度:7.0 | 投稿命中率:50.0 经验分享：3月底投稿，5月中一审，修改3次，润色1次，这个月已经online了。总体看来没有你们说的那么慢。但在等的时候，的确时间过得很慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3424242342, createdTime=Fri Nov 05 19:59:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917758, encodeId=a2fd91e75862, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：见过审稿慢的，但是真的没有见过这么慢的！Awaiting Decision快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=533, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Jan 18 16:07:29 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806224, encodeId=71ac80622419, content=没有战友投稿过吗？一审1.5月，修回还会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Wed Aug 05 07:17:38 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198039, encodeId=a2b7119803956, content=审稿速度:6.0 经验分享：21年10月8日投稿，12月初给了大修，12月底修回，22年2月24接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Mon Feb 28 15:23:17 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970605, encodeId=10c59e0605a0, content=偏重的研究方向：外科 ; 肿瘤 经验分享：前几天刚被接收，想问一下见刊需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8165418207, createdName=ms9000000466598327, createdTime=Thu Jun 03 15:41:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海)]

2023-01-22 1465389cm38暂无昵称来自四川省

偏重的研究方向：肿瘤
经验分享：两个月，从投稿到接收

45 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067378, encodeId=a0f6106e37895, content=审稿速度:7.0 | 投稿命中率:50.0 经验分享：3月底投稿，5月中一审，修改3次，润色1次，这个月已经online了。总体看来没有你们说的那么慢。但在等的时候，的确时间过得很慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3424242342, createdTime=Fri Nov 05 19:59:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917758, encodeId=a2fd91e75862, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：见过审稿慢的，但是真的没有见过这么慢的！Awaiting Decision快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=533, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Jan 18 16:07:29 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806224, encodeId=71ac80622419, content=没有战友投稿过吗？一审1.5月，修回还会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Wed Aug 05 07:17:38 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198039, encodeId=a2b7119803956, content=审稿速度:6.0 经验分享：21年10月8日投稿，12月初给了大修，12月底修回，22年2月24接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Mon Feb 28 15:23:17 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970605, encodeId=10c59e0605a0, content=偏重的研究方向：外科 ; 肿瘤 经验分享：前几天刚被接收，想问一下见刊需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8165418207, createdName=ms9000000466598327, createdTime=Thu Jun 03 15:41:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海)]

2022-12-13 1871fae16em 来自江苏省

偏重的研究方向：肿瘤
经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久

46 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067378, encodeId=a0f6106e37895, content=审稿速度:7.0 | 投稿命中率:50.0 经验分享：3月底投稿，5月中一审，修改3次，润色1次，这个月已经online了。总体看来没有你们说的那么慢。但在等的时候，的确时间过得很慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3424242342, createdTime=Fri Nov 05 19:59:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917758, encodeId=a2fd91e75862, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：见过审稿慢的，但是真的没有见过这么慢的！Awaiting Decision快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=533, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Jan 18 16:07:29 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806224, encodeId=71ac80622419, content=没有战友投稿过吗？一审1.5月，修回还会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Wed Aug 05 07:17:38 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198039, encodeId=a2b7119803956, content=审稿速度:6.0 经验分享：21年10月8日投稿，12月初给了大修，12月底修回，22年2月24接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Mon Feb 28 15:23:17 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970605, encodeId=10c59e0605a0, content=偏重的研究方向：外科 ; 肿瘤 经验分享：前几天刚被接收，想问一下见刊需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8165418207, createdName=ms9000000466598327, createdTime=Thu Jun 03 15:41:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海)]

2024-01-02 ms5451321233 来自上海

审稿速度:6.0 | 投稿命中率:50.0
经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待

19 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067378, encodeId=a0f6106e37895, content=审稿速度:7.0 | 投稿命中率:50.0 经验分享：3月底投稿，5月中一审，修改3次，润色1次，这个月已经online了。总体看来没有你们说的那么慢。但在等的时候，的确时间过得很慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3424242342, createdTime=Fri Nov 05 19:59:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917758, encodeId=a2fd91e75862, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：见过审稿慢的，但是真的没有见过这么慢的！Awaiting Decision快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=533, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Jan 18 16:07:29 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806224, encodeId=71ac80622419, content=没有战友投稿过吗？一审1.5月，修回还会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Wed Aug 05 07:17:38 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198039, encodeId=a2b7119803956, content=审稿速度:6.0 经验分享：21年10月8日投稿，12月初给了大修，12月底修回，22年2月24接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Mon Feb 28 15:23:17 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970605, encodeId=10c59e0605a0, content=偏重的研究方向：外科 ; 肿瘤 经验分享：前几天刚被接收，想问一下见刊需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8165418207, createdName=ms9000000466598327, createdTime=Thu Jun 03 15:41:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海)]

2024-02-16 葵810 来自弗吉尼亚

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤;临床
经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。

18 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1067378, encodeId=a0f6106e37895, content=审稿速度:7.0 | 投稿命中率:50.0 经验分享：3月底投稿，5月中一审，修改3次，润色1次，这个月已经online了。总体看来没有你们说的那么慢。但在等的时候，的确时间过得很慢。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=ms3424242342, createdTime=Fri Nov 05 19:59:49 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917758, encodeId=a2fd91e75862, content=审稿速度:12.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：见过审稿慢的，但是真的没有见过这么慢的！Awaiting Decision快1个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=533, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Jan 18 16:07:29 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=806224, encodeId=71ac80622419, content=没有战友投稿过吗？一审1.5月，修回还会被拒稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=139, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/c00242ccb692f0fc07af23dc30809e82/4340b0461b88d04d2cb3cf232a69b8df.jpg, createdBy=ee272000038, createdName=赤脚草医, createdTime=Wed Aug 05 07:17:38 CST 2020, time=2020-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198039, encodeId=a2b7119803956, content=审稿速度:6.0 经验分享：21年10月8日投稿，12月初给了大修，12月底修回，22年2月24接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLqLOibNbJ5fe7ZgWdc2EwaGjMric5Ticib0JMZPdSl7gJ9xxmKggpibcdu6m96mthQbgroZOKh46cmBrA/132, createdBy=4c4f5156312, createdName=Black doctor, createdTime=Mon Feb 28 15:23:17 CST 2022, time=2022-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970605, encodeId=10c59e0605a0, content=偏重的研究方向：外科 ; 肿瘤 经验分享：前几天刚被接收，想问一下见刊需要多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=94, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b8165418207, createdName=ms9000000466598327, createdTime=Thu Jun 03 15:41:55 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2111127, encodeId=e5ce211112e4a, content=偏重的研究方向：肿瘤 经验分享：两个月，从投稿到接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=969f5129926, createdName=1465389cm38暂无昵称, createdTime=Sun Jan 22 09:23:02 CST 2023, time=2023-01-22, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2105881, encodeId=c66a21058812b, content=偏重的研究方向：肿瘤 经验分享：速度还行，三个审稿人，蛮多意见的，让我按照审稿人意见修改。但是编辑的意见是拒稿重投，时间给的也蛮久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=50162122001, createdName=1871fae16em, createdTime=Tue Dec 13 19:42:51 CST 2022, time=2022-12-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178715, encodeId=917521e87157a, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：这期刊编辑负责任，提出的建议都非常中肯，真的为投稿者着想。感觉得到了认真的对待, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24a26407073, createdName=ms5451321233, createdTime=Tue Jan 02 09:35:06 CST 2024, time=2024-01-02, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2187630, encodeId=b280218e63006, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤;临床 经验分享：千万别投。2023年11月投稿，1月中旬初审结束，建议返修。执行编辑，伦理编辑，总编辑，一大堆表格要填。4个审稿人，总共快40个意见！！审稿意见简直无语，连基本的TNM分期也要解释，回馈的意见云里雾里，根本看不懂。这还是初审啊........才2分多的杂志，同学们避雷吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202402/b69014f9a24941148cec0d353b49d063.jpg, createdBy=52492106226, createdName=葵810, createdTime=Fri Feb 16 10:41:14 CST 2024, time=2024-02-16, status=1, ipAttribution=弗吉尼亚), GetPortalCommentsPageByObjectIdResponse(id=2178724, encodeId=37b721e872475, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b2bc6407064, createdName=ms448552511, createdTime=Tue Jan 02 09:42:45 CST 2024, time=2024-01-02, status=1, ipAttribution=上海)]

2024-01-02 ms448552511 来自上海

审稿速度:2.0 | 投稿命中率:50.0
经验分享：自引率只有2.2%而且很稳定，发文量不算多，但内容都还很不错

15 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务